PRESS RELEASE published on 12/17/2025 at 09:30, 5 months 1 day ago Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth Topadur Pharma AG appoints Matthias Schäfer as Chief Executive Officer to lead company growth into next phase of clinical development and expansion. Dr. Reto Naef transitions to Senior Scientific Advisor Clinical Development Chief Executive Officer Topadur Pharma AG Matthias Schäfer Scientific Advisor
PRESS RELEASE published on 12/17/2025 at 09:30, 5 months 1 day ago Designated Person Notification Aperam announces Designated Person Notification regarding share transactions as per Market Abuse Regulations. Aperam is a global stainless steel player committed to the circular economy Share Transactions Market Abuse Regulations Aperam Circular Economy Designated Person Notification
PRESS RELEASE published on 12/17/2025 at 09:21, 5 months 1 day ago Heidelberg Pharma: Letter from the CEO Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
PRESS RELEASE published on 12/17/2025 at 09:05, 5 months 1 day ago Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment
PRESS RELEASE published on 12/17/2025 at 09:05, 5 months 1 day ago Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies BioNxt Solutions Inc. announces breakthrough in drug delivery for dysphagia, securing first national-level patent for thin-film platform, targeting autoimmune markets with bioequivalent cladribine treatment BioNxt Solutions Inc. Drug Delivery Dysphagia Thin-film Platform Autoimmune Markets
PRESS RELEASE published on 12/17/2025 at 09:00, 5 months 1 day ago Financial Conduct Authority: Financial Conduct Authority admits multiple securities to the Official List on 17-Dec-2025, including shares, ETFs, and debt-like securities from various issuers Securities Financial Conduct Authority Official List Issuers Debt-like Securities
PRESS RELEASE published on 12/17/2025 at 09:00, 5 months 1 day ago Removal- Diversity Funding No. 1 Limited Financial Conduct Authority removes Diversity Funding No. 1 Limited securities from the Official List on 17/12/2025, 08:00 GMT. Debt-like securities delisted Securities Financial Conduct Authority Official List Debt-like Securities Diversity Funding No. 1 Limited
PRESS RELEASE published on 12/17/2025 at 08:30, 5 months 1 day ago Neo Energy Metals plc - Restoration The Financial Conduct Authority restores Neo Energy Metals plc to the Official List, effective from 17/12/2025, 07:30 GMT/BST Financial Conduct Authority Equity Shares Restoration Official List Neo Energy Metals Plc
PRESS RELEASE published on 12/17/2025 at 08:30, 5 months 1 day ago GLOBAL ESG MONITOR 2025: MATERIALITY ANALYSIS WIDELY ADOPTED – INTEGRATION INTO RISIK MANAGEMENT SHOWS GAPS Global ESG Monitor 2025 reveals gaps in integrating materiality analysis into risk management among DAX companies, showcasing discrepancies with stakeholder expectations Risk Management ESG Materiality Analysis DAX Companies Stakeholder Expectations
PRESS RELEASE published on 12/17/2025 at 08:30, 5 months 1 day ago Aquis Stock Exchange: Suspension from trading Valereum Plc's Ordinary Shares (Symbol: VLRM, ISIN: GI000A2P2W41) suspended from trading on Aquis Stock Exchange's Growth Market as of 17th Dec 2025 08:00 GMT/BST Ordinary Shares Trading Aquis Stock Exchange Suspension Valereum Plc
Published on 05/16/2026 at 01:15, 2 days 11 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 2 days 13 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/18/2026 at 13:05, 8 minutes ago Control Risks announces appointment of Bill Udell as Chief Executive Officer
Published on 05/18/2026 at 12:45, 28 minutes ago Emaar Properties exits the JV structure for The Eighth Gate, Damascus
Published on 05/18/2026 at 12:43, 30 minutes ago EQS-Adhoc: MPH Health Care AG: Supervisory Board adopts annual financial statements 2025. Dividend proposal of EUR 5.00 per share
Published on 05/18/2026 at 12:41, 33 minutes ago Commerzbank Board of Managing Directors and Supervisory Board recommend that shareholders not accept UniCredit’s exchange offer – greater value creation through successful stand-alone strategy
Published on 05/18/2026 at 11:06, 2 hours 8 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From May 11th to May 15th 2026
Published on 05/18/2026 at 08:30, 4 hours 44 minutes ago Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Published on 05/15/2026 at 15:08, 2 days 22 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 17:45, 4 days 19 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.